Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06703099 · ClinicalTrials.gov registry record · NA
Magnesium Supplementation on Body Composition
A NA study, sponsored by Nova Southeastern University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT06703099 is a NA study that has completed, run by Nova Southeastern University. The registered enrollment target is 12 participants.
The verdict
NCT06703099, a NA study, has completed, sponsored by Nova Southeastern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The goal of this interventional clinical trial is to learn if the supplementation of magnesium can affect body composition in physically active individuals between the ages of 18 and 30. The main question\[s\] it aims to answer \[is/are\]: How does magnesium supplementation affect body composition in physically active individuals? Participants will take a magnesium capsule once daily for 8 weeks, log their food intake into MyFitnessPal 3 days weekly for the 8 weeks, keep their physical activity consistent to their current regimen, and have 1 baseline appointment with 2 follow ups evenly dispersed (mid-point and post-intervention).
Interventions
- DIETARY_SUPPLEMENT Magnesium Supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2024-09-25 |
| Est. Completion | 2025-04-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06703099
The ClinicalTrials.gov registry entry for NCT06703099 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magnesium Supplementation is the first listed.
NCT06703099 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06703099 about?
NCT06703099 is a clinical study titled "Magnesium Supplementation on Body Composition". The goal of this interventional clinical trial is to learn if the supplementation of magnesium can affect body composition in physically active individuals between the ages of 18 and 30. The main question\[s\] it aims to answer \[is/are\]: How does magnesium supplementation affect body composition ...
What is the current status of trial NCT06703099?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2024-09-25. Estimated completion is 2025-04-27.
What interventions are being tested in trial NCT06703099?
The interventions under investigation include: Magnesium Supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06703099?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.